153
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The INSPIRE Comparative Cost Study: 12-Month Health Economic and Clinical Outcomes Associated with Hysterectomy, Myomectomy, and Treatment with the Sonata System

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , , ORCID Icon & show all
Pages 1-11 | Published online: 08 Jan 2020

References

  • Williams VSL, Jones G, Mauskopf J, Spalding J, Duchane J. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health. 2006;15(7):818–829. doi:10.1089/jwh.2006.15.818
  • Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi:10.1067/mob.2003.99
  • Lagana AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296:855–867. doi:10.1007/s00404-017-4515-5
  • Barrett ML, Weiss AJ, Stocks C, Steiner CA, Myers ER. Procedures to treat Benign Uterine Fibroids in hospital inpatient and hospital-based ambulatory surgery settings, 2013: statistical brief #200. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006. Available from: http://www.ncbi.nlm.nih.gov/books/NBK349622/. Accessed February 2, 2018.
  • Brummer T, Jalkanen J, Fraser J, et al. FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors. Hum Reprod. 2011;26(7):1741–1751. doi:10.1093/humrep/der116
  • Prapas Y, Kalogiannidis I, Prapas N. Laparoscopy vs laparoscopically assisted myomectomy in the management of uterine myomas: aprospective study. Am J Obstet Gynecol. 2009;200(2):144.e1–144.e6. doi:10.1016/j.ajog.2008.08.063
  • Kong CY, Omer ZB, Pandharipande PV, et al. MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol. 2014;203(2):361–371. doi:10.2214/AJR.13.11446
  • Fitch K, Huh W, Bochner A. Open vs. minimally invasive hysterectomy: commercially insured costs and readmissions. Manag Care Langhorne Pa. 2016;25(8):40–47.
  • Bonafede MM, Pohlman SK, Miller JD, Thiel E, Troeger KA, Miller CE. Women with newly diagnosed uterine fibroids: treatment patterns and cost comparison for select treatment options. Popul Health Manag. 2018;21(S1):S13–S20. doi:10.1089/pop.2017.0151
  • Cain-Nielsen AH, Moriarty JP, Stewart EA, Borah BJ. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA. J Comp Eff Res. 2014;3(5):503–514. doi:10.2217/cer.14.32
  • Desormeaux P Gynecological Devices. United States: Decision Resources Group; 2018. Available from: https://decisionresourcesgroup.com/report/576432-medtech-gynecological-devices-medtech-360-market/.Accessed December 11, 2019.
  • Lagana AS, Pacheco LA, Tinelli A, et al. Management of asymptomatic submucous myomas in women of reproductive age. A consensus statement from the global congress on hysteroscopy scientific committee. J Minim Invasive Gynecol. 2019;26(3):381–383. doi:10.1016/j.jmig.2018.06.020
  • Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal J. Ultrasound-guided transcervical ablation of uterine leiomyomas. Obstet Gynecol. 2019;133(1):13–22. doi:10.1097/AOG.0000000000003032
  • Medicare and commercial health insurance: the fundamental difference. Available from: https://www.healthaffairs.org/do/10.1377/hblog20120215.016980/full/. Accessed July 25, 2018.
  • Truven health analytics.
  • Smith MW, Friedman B, Karaca Z, Wong HS. Predicting inpatient hospital payments in the United States: a retrospective analysis. BMC Health Serv Res. 2015;15:372. doi:10.1186/s12913-015-1040-8
  • Clemens J, Gottlieb JD. In the shadow of a giant: medicare’s influence on private physician payments. J Polit Econ. 2016;125(1):1–39. doi:10.1086/689772
  • Maeda J, Nelson L An analysis of private-sector prices for hospital admissions. Working Paper 2017-02. April 2017.
  • O’Sullivan A, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care. 2009;25(1):14–25. doi:10.1017/S0266462309090035
  • CPI inflation calculator. Available from: https://www.bls.gov/data/inflation_calculator.htm. Accessed February 2, 2018.
  • Soliman AM, Yang H, Du EX, Kelkar SS, Winkel C. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015;213(2):141–160. doi:10.1016/j.ajog.2015.03.019